.
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Graniela-father-of-Larabel-from-Mont-de-vougney?Maddockbr=207
.
.
.
-
.